Media Coverage · November 26, 2014
Gilles Avenard guest of “Innover et Investir dans la Santé” (Innovate and Invest in Health) conference
Gilles Avenard, Acticor Biotech CEO is invited to talk about the relationships between Business Angels and startups in the field of human health.
The “Innover et Investir dans la Santé” (Innovate and Invest in Health) conference is organized by Angels Santé, the leading Business Angels network in France, and the Public Bank for Investment (BPI), during the French Business Angels Week of 2014.
More information in French on Business Angels Sante.
Read next in 'Media Coverage'
- AVC : les promesses de la science - l'Express [FR]
- Pharmacie : La Chine s'éveille - Le Figaro [FR]
- AVC, un candidat médicament - La revue du practicien [FR]
- Un nouvel antithrombotique en développement - Le quotidien du pharmacien [FR]
- la start-up Acticor, qui développe un traitement contre les AVC, a bouclé une levée de fonds en série B de 15,3 millions d'euros - Les Echos [FR]